High‐throughput screening assays for SARS‐CoV‐2 drug development: Current status and future directions

In response to the ongoing coronavirus disease 2019 (COVID-19) pandemic, a panel of assays has been developed and applied to screen collections of approved and investigational drugs for anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) activity in a quantitative high-throughput scree...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Tuan, Zheng, Wei, Huang, Ruili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd. ;, Distributed by Virgin Mailing and Distribution 2021
Materias:
Post-Screen (Grey)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146264/
https://www.ncbi.nlm.nih.gov/pubmed/34048893
http://dx.doi.org/10.1016/j.drudis.2021.05.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146264/
https://www.ncbi.nlm.nih.gov/pubmed/34048893
http://dx.doi.org/10.1016/j.drudis.2021.05.012

Ejemplares similares